Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases.

Xinran Li, Amy Y T Lau, Angel S N Ng, Abdullah Aldehaiman, Yuan Zhou, Patrick K S Ng, Stefan T. Arold, Lydia W T Cheung

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases.'. Together they form a unique fingerprint.

Medicine & Life Sciences